Copyright
©The Author(s) 2020.
World J Gastrointest Endosc. Oct 16, 2020; 12(10): 401-403
Published online Oct 16, 2020. doi: 10.4253/wjge.v12.i10.401
Published online Oct 16, 2020. doi: 10.4253/wjge.v12.i10.401
Table 1 Comparison of gastrointestinal endoscopy performed in 2019 and 2020
| 2020 | 2019 | P value | |
| Upper endoscopy, n | 311 | 790 | |
| Colonoscopy, n | 233 | 537 | |
| Total, n | 544 | 1327 | |
| Age (yr ± SD) | 55.2 ± 13.4 | 55.8 ± 13.2 | 0.34 |
| Sex, male (%) | 53.9 | 47.3 | 0.01 |
| All malignancies, n (%) | 6 (1.1) | 8 (0.6) | 0.40 |
| Advanced lesion, n (%) | 5 (0.9) | 2 (0.2) | 0.04 |
| Early lesion, n (%) | 1 (0.2) | 6 (0.5) | 0.66 |
- Citation: Yoshida S, Nishizawa T, Toyoshima O. Real-world clinical data of endoscopy-based cancer detection during the emergency declaration for COVID-19 in Japan. World J Gastrointest Endosc 2020; 12(10): 401-403
- URL: https://www.wjgnet.com/1948-5190/full/v12/i10/401.htm
- DOI: https://dx.doi.org/10.4253/wjge.v12.i10.401